Composition for inhibiting cancer metastasis containing DLK1-Fc fusion protein as an active ingredient

Details for Australian Patent Application No. 2010348423 (hide)

Owner Korea Research Institute of Bioscience and Biotechnology

Inventors Park, Young Woo; Jo, Kiwon; Lee, Donghee; Yu, Jung; Park, Ji Hyun; Park, Chan-Woong; Kim, Eun Jin; Park, Yun Jung

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010348423

PCT Pub. Number WO2011/115323

Priority 10-2010-0023180 16.03.10 KR

Filing date 13 April 2010

Wipo publication date 22 September 2011

International Classifications

C07K 14/475 Peptides having more than 20 amino acids

C07K 19/00 Hybrid peptides

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/115323 Priority application(s): WO2011/115323

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010348477-Method for cutting carbon fiber base

2010348409-Production of proteins and polypeptides